Clinical Trial

Clinical Study of ATTR-CM

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT04935021
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Transthyroxine Amyloidosis Cardiomyopathy
Enrollment 100 participants
Start Date 2021-06-01
Primary Completion 2031-06-01 (estimated)
Study Completion 2031-06-01 (estimated)
Updated on ClinicalTrials.gov 2023-01-31